A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression. (2024)
Attributed to:
Psychosis Immune Mechanism Stratified Medicine Study (PIMS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.psyneuen.2024.107008
PubMed Identifier: 38442505
Publication URI: http://europepmc.org/abstract/MED/38442505
Type: Journal Article/Review
Volume: 164
Parent Publication: Psychoneuroendocrinology
ISSN: 0306-4530